Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-004735

President and CEO sold 30,000 shares at an average $33.91 ($1,017,430)

  • President and CEO acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Coulie Bernard President and CEO 2023-02-02 Option exercise +15,000 $6.22 $93,300 255,112 D
Coulie Bernard President and CEO 2023-02-02 Sale −13,395 $34.13 $457,124 241,717 D
Coulie Bernard President and CEO 2023-02-02 Sale −1,605 $34.96 $56,105 240,112 D
Coulie Bernard President and CEO 2023-02-03 Option exercise +15,000 $6.22 $93,300 255,112 D
Coulie Bernard President and CEO 2023-02-03 Sale −9,738 $33.36 $324,888 245,374 D
Coulie Bernard President and CEO 2023-02-03 Sale −5,262 $34.08 $179,312 240,112 D
Derivatives
Coulie Bernard President and CEO 2023-02-02 Option exercise · Stock Option (right to buy) −15,000 342,262 D
Coulie Bernard President and CEO 2023-02-03 Option exercise · Stock Option (right to buy) −15,000 327,262 D
Open-market sales · 30,000 sh · avg $33.91 · $1,017,430
Loading xslF345X03/form4.xml…